Bahce et al. performed dPET studies with 11C-erlotinib and 15O-H2O and applied compartmental analysis in 13 patients with advanced, epidermal growth factor receptor (EGFR)-mutated nonsmall-cell lung cancer [81]. The gene discussed is EGFR; the disease is lung cancer.